Kane Biotech's total assets for Q3 2024 were C$3.91M, a decrease of -4.14% from the previous quarter. TSE:KNE total liabilities were C$4.59M for the fiscal quarter, a -4.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.